Fei Li

11PUBLICATIONS
45CO-AUTHORS
Molecular targetsRespiratory diseasesHaematological tumoursHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 22, 2026
Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.

|Oct 28, 2025
Combination Therapy with Romiplostim, Danazol, and a Thrombopoietin Receptor Agonist for Immune Restoration in Chronic Refractory Immune Thrombocytopenia: A Case Series.

Shi-Xuan Wang, Gen-Mei Tan, Zhi-Ming Zou

|May 09, 2025
Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.

Si-Yuan Chen, Peng-Peng Xu, Ru Feng

|Jan 06, 2025
Hematopoietic stem cell microtransplantation: current situation and challenges.

Zhengyang Li, Yuanyuan Yang, Hongwei Peng

|Sep 19, 2024
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma.

Jie Jin, Hong Cen, Keshu Zhou

|Sep 18, 2024
Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia.

Ran Zhao, Dexiang Ji, Yulan Zhou

Pageof 2

Frequent Collaborators

2 joint publications

Hanying Bao

2 joint publications

Zusheng Xu

2 joint publications

Zhiming Li

2 joint publications

Jie Jin